Jones Financial Companies
FLGT icon

Jones Financial Companies’s Fulgent Genetics FLGT Stock Holding History

Jones Financial Companies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51K Sell
289
-152
-34% -$3.3K ﹤0.01% 3887
2025
Q4 		$11.6K Buy
441
+132
+43% +$3.42K ﹤0.01% 3156
2025
Q3 		$6.98K Buy
309
+273
+758% +$5.62K ﹤0.01% 3217
2025
Q2 		$708 Sell
36
-131
-78% -$2.55K ﹤0.01% 3738
2025
Q1 		$2.85K Buy
167
+93
+126% +$1.58K ﹤0.01% 3152
2024
Q4 		$1.37K Sell
74
-19
-20% -$371 ﹤0.01% 3082
2024
Q3 		$1.97K Buy
93
+13
+16% +$291 ﹤0.01% 2679
2024
Q2 		$1.57K Buy
+80
New +$1.67K ﹤0.01% 2208

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jones Financial Companies's FLGT Position: Q1 2026 in Review

Jones Financial Companies reduced its Fulgent Genetics (FLGT) stake by 34% in Q1 2026, selling an estimated $3.3K and leaving 289 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3887.

Jones Financial Companies first reported a position in FLGT in Q2 2024 and has held it in 8 quarters since. The position peaked at $11.6K in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Jones Financial Companies held 289 shares of Fulgent Genetics worth $4.51K as of Q1 2026.
  • Jones Financial Companies sold 152 Fulgent Genetics shares in Q1 2026, an estimated $3.3K.
  • Fulgent Genetics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3887 holding.
  • Jones Financial Companies first reported a position in Fulgent Genetics in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Fulgent Genetics position peaked at $11.6K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.